1
TITLE: Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
AUTHORS: João Pedro Ferreira ; David Fitchett; Anne Pernille Ofstad; Bettina Johanna Kraus; Christoph Wanner; Isabella Zwiener; Bernard Zinman; Sabine Lauer; Jyothis T George; Patrick Rossignol; Faiez Zannad;
PUBLISHED: 2020, SOURCE: American Journal of Hypertension, VOLUME: 33, ISSUE: 12
INDEXED IN: CrossRef: 23
2
TITLE: Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME (R) trial
AUTHORS: Pedro Monteiro; Richard M Bergenstal; Elvira Toural; Silvio Inzucchi; Bernard Zinman; Stefan Hantel; Sanja Giljanovic Kis; Stefan Kaspers; Jyothis T George; David Fitchett;
PUBLISHED: 2019, SOURCE: AGE AND AGEING, VOLUME: 48, ISSUE: 6
INDEXED IN: Scopus WOS
3
TITLE: Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline  Full Text
AUTHORS: James Januzzi; João Pedro Ferreira ; Michael Böhm; Sanjay Kaul; Christoph Wanner; Martina Brueckmann; Mark C Petrie; Anne Pernille Ofstad; Cordula Zeller; Jyothis George; David Fitchett; Faiez Zannad;
PUBLISHED: 2019, SOURCE: European Journal of Heart Failure, VOLUME: 21, ISSUE: 3
INDEXED IN: CrossRef: 23